Articles By Cyndi Root

  1. Southern Biologics Network Launches To Develop Biological Treatments 12/12/2014

    A public-private partnership, Southern Biologics Network (SBN), has launched in Alabama, North Carolina, and Louisiana to develop biological treatments.

  2. Seattle Genetics, Takeda Report Positive Adcetris Data In Lymphoma Studies 12/10/2014

    Seattle Genetics and Takeda Pharmaceutical Company report positive results from Adcetris studies to treat lymphoma.

  3. Bristol-Myers Squibb, Pfizer Report 4-Factor PCCs Reverse Anticoagulant Effect Of Eliquis 12/10/2014

    Bristol-Myers Squibb (BMS) and Pfizer report that 4-factor prothrombin complex concentrates (PCCs) reverse the anticoagulant effect of Eliquis (apixaban).

  4. Evotec, Sanofi Partner, Promise Innovation 12/9/2014

    Evotec and Sanofi have entered a partnership, which they state is “a major multi-component strategic alliance.” The companies announced the collaboration in a press release, stating that they will bridge innovation from the laboratory to the market, focus on oncology, and innovate in pre-clinical discovery.

  5. Modern Biosciences, Janssen Partner On Rheumatoid Arthritis Treatments 12/5/2014

    Modern Biosciences (MBS) has partnered with Janssen Biotech on the development of new drugs for rheumatoid arthritis (RA).

  6. Ikaria, Lee's Partner On Inomax For Hypoxic Respiratory Failure 12/2/2014

    Ikaria and its INO Therapeutics subsidiary has partnered with Lee's Pharmaceutical on the registration and commercialization of Ikaria's Inomax (inhaled nitric oxide).

  7. CRT Pioneer Fund, Cancer Research UK Manchester Partner On Lung Cancer Drugs 11/26/2014

    The Cancer Research Technology Pioneer Fund (CPF) has partnered with the Cancer Research UK Manchester Institute Drug Discovery Unit on RET inhibitors to treat lung cancer, Cancer Research UK announced in a press release.

  8. China's Yabao, MRC Technology Partner On Parkinson's Therapeutics 11/26/2014

    Yabao Pharmaceuticals has partnered with MRC Technology to develop therapeutics for Parkinson’s disease.

  9. Amgen Opens Biologics Manufacturing Facility In Singapore 11/25/2014

    Amgen has finished construction of its biologics manufacturing facility in Tuas, Singapore.

  10. Bristol-Myers Squibb, Five Prime Partner On Opdivo, FPA008 In Tumors 11/25/2014

    Bristol-Myers Squibb Company (BMS) and Five Prime Therapeutics have entered into a partnership to investigate a combination of BMS’ Opdivo (nivolumab) and Five Prime’s FPA008 to treat six types of malignant tumors.